Expression of Concern Reaffirmed
Open Access
- 16 March 2006
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 354 (11), 1193
- https://doi.org/10.1056/nejme068054
Abstract
On December 8, 2005, we published an expression of concern1 regarding an article by Bombardier et al. on the Vioxx Gastrointestinal Outcomes Research (VIGOR) study that was published in the Journal on November 23, 2000.2 Our expression of concern was prompted by evidence that the VIGOR article did not accurately represent the safety data available to the authors when the article was being reviewed for publication.Keywords
This publication has 3 references indexed in Scilit:
- Response to Expression of Concern Regarding VIGOR StudyThe New England Journal of Medicine, 2006
- Expression of Concern: Bombardier et al., “Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis,” N Engl J Med 2000;343:1520-8.The New England Journal of Medicine, 2005
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisThe New England Journal of Medicine, 2000